Effect of mechanical tension on fibroblast transcriptome profile and regulatory mechanisms of myocardial collagen turnover

Excess deposition of extracellular matrix in the myocardium is a predictor of reduced left ventricular function. Although reducing the hemodynamic load is known to improve myocardial fibrosis, the mechanisms underlying the reversal of the fibrosis have not been elucidated. We focused on the elasticity of myocardial tissue, which is assumed to influence the fibroblast phenotype. Normal and fibrotic myocardium were cultured in 16 kPa and 64 kPa silicone gel‐coated dishes supplemented with recombinant TGFβ protein, respectively. Matrix‐degrading myocardium was cultured in 64 kPa silicone gel‐coated dishes with recombinant TGFβ protein and then in 16 kPa silicone gel‐coated dishes. Cardiac fibroblasts were cultured in this three‐part in vitro pathological models and compared. Fibroblasts differentiated into activated or matrix‐degrading types in response to the pericellular environment. Comprehensive gene expression analysis of fibroblasts in each in vitro condition showed Selenbp1 to be one of the genes responsible for regulating differentiation of fibroblasts. In vitro knockdown of Selenbp1 enhanced fibroblast activation and inhibited conversion to the matrix‐degrading form. In vivo knockdown of Selenbp1 resulted in structural changes in the left ventricle associated with progressive tissue fibrosis and left ventricular diastolic failure. Selenbp1 is involved in regulating fibroblast differentiation and appears to be one of the major molecules regulating collagen turnover in cardiac fibrosis.

[1]  Lunxu Liu,et al.  Withdrawal Notice , 2022, Cancer medicine.

[2]  N. Kimura,et al.  Early cardiac contractility outcome of reoperative coronary artery bypass grafting using right gastroepiploic artery , 2021, Journal of cardiac surgery.

[3]  P. Ray,et al.  Cardiolipin-mediated PPARγ S112 phosphorylation impairs IL-10 production and inflammation resolution during bacterial pneumonia , 2021, Cell reports.

[4]  A. Nebreda,et al.  Diversity and versatility of p38 kinase signalling in health and disease , 2021, Nature Reviews Molecular Cell Biology.

[5]  Yulei N. Wang,et al.  Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer , 2020, Journal of Translational Medicine.

[6]  B. Hinz,et al.  Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases , 2019, Nature Reviews Rheumatology.

[7]  B. Hinz,et al.  Mechanical regulation of myofibroblast phenoconversion and collagen contraction. , 2019, Experimental cell research.

[8]  N. Frangogiannis Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. , 2019, Molecular aspects of medicine.

[9]  A. Diamond,et al.  Selenium-Binding Protein 1 in Human Health and Disease , 2018, International journal of molecular sciences.

[10]  J. Eble,et al.  More than a syllable in fib-ROS-is: The role of ROS on the fibrotic extracellular matrix and on cellular contacts. , 2018, Molecular aspects of medicine.

[11]  D. Lagares,et al.  BH3 mimetics as anti-fibrotic therapy: Unleashing the mitochondrial pathway of apoptosis in myofibroblasts. , 2018, Matrix biology : journal of the International Society for Matrix Biology.

[12]  J. Lu,et al.  Hesperetin Mitigates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting Extracellular Matrix and Cell Apoptosis via the TGF-β1/Smad Pathway. , 2018, Current molecular medicine.

[13]  Alba Santos,et al.  Matrix Stiffness: the Conductor of Organ Fibrosis , 2018, Current Rheumatology Reports.

[14]  A. Letai,et al.  Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis , 2017, Science Translational Medicine.

[15]  G. Christensen,et al.  Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy , 2017, Scientific Reports.

[16]  T. Quertermous,et al.  Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment , 2016, Nature Communications.

[17]  J. Liao,et al.  Rho Kinases and Cardiac Remodeling. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[18]  H. Adachi,et al.  Alternatively activated macrophages determine repair of the infarcted adult murine heart. , 2016, The Journal of clinical investigation.

[19]  K. Yutzey,et al.  Cardiac Fibrosis: The Fibroblast Awakens. , 2016, Circulation research.

[20]  M. Kural,et al.  Myofibroblast persistence with real-time changes in boundary stiffness. , 2016, Acta biomaterialia.

[21]  Y. Ichihara,et al.  Allogeneic Mesenchymal Stromal Cells Transplanted Onto the Heart Surface Achieve Therapeutic Myocardial Repair Despite Immunologic Responses in Rats , 2016, Journal of the American Heart Association.

[22]  J. Hoeijmakers,et al.  An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. , 2014, Developmental cell.

[23]  P. Muret,et al.  In vitro study of the impact of mechanical tension on the dermal fibroblast phenotype in the context of skin wound healing. , 2014, Journal of biomechanics.

[24]  P. Kang,et al.  RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis , 2014, Science Signaling.

[25]  Nobuko Tano,et al.  Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  B. Borlaug,et al.  The pathophysiology of heart failure with preserved ejection fraction , 2014, Nature Reviews Cardiology.

[27]  B. Hinz,et al.  Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction. , 2014, Cardiovascular research.

[28]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[29]  N. Frangogiannis,et al.  The pathogenesis of cardiac fibrosis , 2014, Cellular and Molecular Life Sciences.

[30]  Mark W. Tibbitt,et al.  Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway , 2013, Proceedings of the National Academy of Sciences.

[31]  S. Ball,et al.  p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts , 2013, Biochemical and biophysical research communications.

[32]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[33]  Mark D. Huffman,et al.  Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[34]  April M. Kloxin,et al.  Redirecting Valvular Myofibroblasts into Dormant Fibroblasts through Light-mediated Reduction in Substrate Modulus , 2012, PloS one.

[35]  M. Kapoor,et al.  Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation. , 2012, Arthritis and rheumatism.

[36]  K. J. Grande-Allen,et al.  Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .

[37]  M. Entman,et al.  CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis. , 2011, American journal of physiology. Heart and circulatory physiology.

[38]  L. Lau,et al.  The Matricellular Protein CCN1/CYR61 Induces Fibroblast Senescence and Restricts Fibrosis in Cutaneous Wound Healing , 2010, Nature Cell Biology.

[39]  Milica Radisic,et al.  Influence of substrate stiffness on the phenotype of heart cells , 2010, Biotechnology and bioengineering.

[40]  Kristi S Anseth,et al.  In situ elasticity modulation with dynamic substrates to direct cell phenotype. , 2010, Biomaterials.

[41]  A. McMahon,et al.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. , 2010, The American journal of pathology.

[42]  Francis G Spinale,et al.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. , 2007, Physiological reviews.

[43]  M. Harmsen,et al.  Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. , 2007, The American journal of pathology.

[44]  K. Fujiwara,et al.  ECM remodeling in hypertensive heart disease. , 2007, The Journal of clinical investigation.

[45]  R. Gomer,et al.  Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice , 2006, Proceedings of the National Academy of Sciences.

[46]  Adam J. Engler,et al.  Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance , 2006 .

[47]  R. Price,et al.  Expression of Discoidin Domain Receptor 2 (DDR2) in the Developing Heart , 2005, Microscopy and Microanalysis.

[48]  C. Long,et al.  The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. , 2005, Annual review of pharmacology and toxicology.

[49]  Tim Baker,et al.  Economic burden of heart failure: a summary of recent literature. , 2004, Heart & lung : the journal of critical care.

[50]  M. Yacoub,et al.  Profibrotic Effects of Endothelin-1 via the ETA Receptor in Cultured Human Cardiac Fibroblasts , 2004, Cellular Physiology and Biochemistry.

[51]  J. Crapo,et al.  Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[53]  Emile R. Mohler,et al.  Bone Formation and Inflammation in Cardiac Valves , 2001, Circulation.

[54]  M. Entman,et al.  Angiotensin II Blockade Reverses Myocardial Fibrosis in a Transgenic Mouse Model of Human Hypertrophic Cardiomyopathy , 2001, Circulation.

[55]  H. Zimmer,et al.  Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture. , 2000, Cardiovascular research.

[56]  A. Sytkowski,et al.  Differential expression and androgen regulation of the human selenium-binding protein gene hSP56 in prostate cancer cells. , 1998, Cancer research.

[57]  M. Waye,et al.  Isolation, characterization, and chromosomal mapping of a novel cDNA clone encoding human selenium binding protein. , 1997, Journal of cellular biochemistry.

[58]  K. Weber,et al.  Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. , 1996, Hypertension.

[59]  J. Ross,et al.  Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[60]  L. Leinwand,et al.  Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization. , 1989, Journal of molecular and cellular cardiology.